KLDO

0.00010.00%
TM

Theodose Melas-Kyriazi

Independent Chairperson of the Board

Mr. Theodose Melas-Kyriazi, also known as Theo, served as the Chairman of the Board at KSQ Therapeutics, Inc until 2023. He serves as the Chairman of the Board at Cygnal Therapeutics, Inc. He is an Independent Director at Kaleido Biosciences, Inc. since July 15, 2019 and serves as a Chairperson of the Board since August 9, 2021. Mr. Melas-Kyriazi serves as a Chief Financial Officer at Thoratec LLC. He serves as an Advisor Partner at Flagship Pioneering, Inc. He was an Executive Partner at Flagship Pioneering, Inc since joining the firm in April 2019. Mr. Melas-Kyriazi serves as the President at Thermo Neslab LLC. He serves as a Chief Financial Officer at Thermo BioAnalysis LLC and Onix Systems Inc. since 1998. Mr. Melas-Kyriazi also has served as Chief Financial Officer at Levitronix Technologies Inc. and its predecessor companies since 2006. Prior to joining Flagship, he served as the Chief Financial Officer at Levitronix Technologies LLC. since 2006. He was an Operating Executive at SFW Capital Partners, L.P. He served as Chief Financial Officer of Metrika Systems Corp. since 1998. He was employed at Thermo Fisher Scientific, Inc., where he worked. In his career at Thermo, he served as a Treasurer, Vice President of Corporate Strategy and Chief Executive Officer of Thermo Spectra Corporation. Mr. Melas-Kyriazi served as Principal Accounting Officer of Thermo Fisher Scientific, Inc. and served as its Chief Financial Officer from January 1, 1999, to October 1, 2004. There, he was instrumental in equity and convertible debt and executed Initial Public Offerings (IPOs) for five of Thermo Fisher?s subsidiary companies. He served as Vice President of Thermo Fisher Scientific, Inc. from 1998 to October 2004. He served as Principal Accounting Officer of Thermo TerraTech Inc. He served as Chief Financial Officer of Thermo TerraTech Inc. since January 01, 1999 and served as its Vice President. He served as the Chief Financial Officer and Vice President at Thermo Instrument Inc. (Thermo Instrument Systems Inc.), Thermedics Inc. Thermo Cardiosystems Inc. Randers Killam Group Inc. and ThermoRetec Corp. since January 1, 1999. He served as Chief Financial Officer of Kadant Fibergen, Inc. since January 01, 1999. He served as Chief Financial Officer of Thoratec Corp. since January 01, 1999. Mr. Melas-Kyriazi served as the Chief Financial Officer at Thermo Power Corporation since 1998. He was affiliated with Thermo Electron Corporation (now Thermo Fisher Scientific) from 1986 to October 2004. He joined Thermo Electron Corp. (now Thermo Fisher Scientific) in 1986 as an Assistant Treasurer and served as the Treasurer from 1988 to 1994. From 1994 to 1997, he served as the President and Chief Executive Officer of Thermo Spectra Corporation. In 1998, he served as the Vice President of Corporate Strategy at Thermo Electron (now Thermo Fisher Scientific). He served as Chief Financial Officer of Thermo Ecotek Corp. ThermoLase Corporation, Thermospectra Corp. ThermoTrex Corporation and Trex Medical Corporation since January 1, 1999. He served as the Treasurer of Thermo Voltek Corp. from January 1991 to September 1994, Thermo Instrument from 1988 to August 1994 and ThermoTrex Corporation since 1988. He was employed at Newport Franklin, Inc. Kadant Inc. Thermo Sentron, Inc. ThermoQuest Corporation, Thermo Optek Corporation and Thermedics Detection. Mr. Melas-Kyriazi served as the Chairman of the Board at Thermospectra Corp. since March 1998. Mr. Melas-Kyriazi had been Independent Director of Evelo Biosciences, Inc. since February 2017 until July 11, 2023. He serves as an Independent Director at Codiak BioSciences, Inc. since November 2019. He served as a Director at Vero Biotech LLC (formerly known as GeNO LLC) since September 2013. He was Director at InterAx Biotech AG until October 2019. He served as a Director at Moderna Therapeutics, Inc. since December 2013 until 2016. He served a Director at Glenrose Instruments Inc. from 2005 to September 30, 2010. He served as a Member of the Board of Directors at Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals International) since 2003 to June 14, 2016. He served as a Director at Cyberkinetics Neurotechnology Systems, Inc. since November 2004. He served as a Director at ThermoSpectra Corporation since August 1994. He served as a Director at Helicos BioSciences Corporation from March 2007 to April 2011 and several private companies. He served as a Director at ThermoRetec Corporation since 1992. Mr. Melas-Kyriazi served as a Director at Thermo Voltek Corp. since 1990 and Thoratec Corp. from February 2001 to October 9, 2003. He served as a Director of Elem? Medical Inc. He received an M.B.A. from The Harvard Business School in 1983 and a B.A. Degree in Economics from Harvard College in 1981.

Positions